Lifting ME/CFS: The OMF’s Unique Two-Drug Clinical Trial to Begin Soon
The Open Medicine Foundations LIFT trial will explore the effects of two drugs - low dose naltrexone and Mestinon on chronic fatigue syndrome (ME/CFS)
The Dan Neuffer Interview on Recovery From ME/CFS and Fibromyalgia Pt. II – Broad Themes and Why He’s Stopped Counting Recovery Stories
In Pt. II of our 4-part interview on how people with chronic fatigue syndrome (ME/CFS) and fibromyalgia (FM) recover, we cover the following topics. I ask what did CFS Unravelled bring that was new – a single explanation 0:00:22 Dan challenges the model of...
The “Serotonin Surprise”: Massive Study Suggests Low Serotonin is Key Factor in Long COVID and Post-Infectious Diseases
A massive study suggested that infection triggered low serotonin levels in long COVID and other post-infectious disease may play a key role in these diseases.
Surprising Findings Dot Day 2 of the Keystone Long-COVID Conference
We continue to take a deep dive into the “Long COVID and Post Acute Sequalae of SARS CoV 2 (PASC): Pathogenesis and Treatment” first-ever international conference on long COVID. Long-COVID research was always going to be a bit messy. Take a look at the...
“Provocative” PET Study Finds Unexpectedly Wide Immune Activation in Long COVID
Could ME/CFS be next? There’s nothing like a pandemic to open new doors on post-infectious diseases, and it’s no surprise that the Henrich/Peluso team at the University of California at San Francisco would be the ones to do that. With their LIINC project,...StudyME
Enroll in the OMF’s StudyME project and help bring about a cure for ME/CFS, fibromyalgia, POTS and long COVID.
